logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11707495 B1

PDFFull Text
Date of Patent:
Jul. 25, 2023

Filed:

Jan. 24, 2020

Recombinant rhabdovirus encoding for ccl21

Applicants:

Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;

Viratherapeutics Gmbh, Rum, AT;

Inventors:

Philipp Mueller, Mittelbiberach, DE;

Klaus Erb, Mittelbiberach, DE;

Patrik Erlmann, Goetzens, AT;

Tobias Friederike Nolden, Birgitz, AT;

John Edward Park, Warthausen, DE;

Guido Wollmann, Innsbruck, AT;

Assignees:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

ViraTherapeutics GmbH, Rum, AT;

Attorney:

Wendy M. Gombert

Primary Examiner:

Nianxiang Zou

Int. Cl.
CPC ...
A61K 35/766 (2015.01); C12N 7/00 (2006.01); A61K 35/00 (2006.01); A61K 31/4375 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 31/4704 (2006.01); A61K 31/4725 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 39/395 (2006.01); C07K 14/52 (2006.01);
U.S. Cl.
CPC ...
A61K 35/766 (2013.01); A61K 9/0019 (2013.01); A61K 31/4375 (2013.01); A61K 31/4704 (2013.01); A61K 31/4725 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); C07K 14/521 (2013.01); C12N 7/00 (2013.01); C12N 2760/20221 (2013.01);
Abstract

The present invention relates to the field of oncolytic viruses and in particular to a recombinant rhabdovirus, such as vesicular stomatitis virus encoding in its genome for a CCL21 protein. The invention is further directed to the use of the recombinant virus in the treatment of cancer, and also to methods for producing such viruses.

Find Patent Forward Citations

Mueller, Philipp. (2023). Recombinant rhabdovirus encoding for ccl21 (U.S. Patent No. 11707495). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11707495

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…